Praxis Precision Medicines (PRAX) Return on Capital Employed: 2022-2025
Historic Return on Capital Employed for Praxis Precision Medicines (PRAX) over the last 3 years, with Sep 2025 value amounting to -0.79%.
- Praxis Precision Medicines' Return on Capital Employed fell 37.00% to -0.79% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.79%, marking a year-over-year decrease of 37.00%. This contributed to the annual value of -0.81% for FY2024, which is 67.00% up from last year.
- According to the latest figures from Q3 2025, Praxis Precision Medicines' Return on Capital Employed is -0.79%, which was down 21.12% from -0.65% recorded in Q2 2025.
- Praxis Precision Medicines' 5-year Return on Capital Employed high stood at -0.41% for Q2 2024, and its period low was -2.40% during Q1 2023.
- In the last 3 years, Praxis Precision Medicines' Return on Capital Employed had a median value of -0.79% in 2025 and averaged -1.02%.
- Its Return on Capital Employed has fluctuated over the past 5 years, first spiked by 153bps in 2024, then crashed by 37bps in 2025.
- Praxis Precision Medicines' Return on Capital Employed (Quarterly) stood at -2.35% in 2022, then surged by 80bps to -1.55% in 2023, then surged by 106bps to -0.49% in 2024, then tumbled by 37bps to -0.79% in 2025.
- Its last three reported values are -0.79% in Q3 2025, -0.65% for Q2 2025, and -0.53% during Q1 2025.